Media Summary: Earlier clinical trials suggest the vaccine causes an immune response in participants. But The trial includes 1000 participants here in Remdesivir is an anti-viral drug being tested at Strong Hospital on 16 patients.

Urmc Enters Another Phase 3 - Detailed Analysis & Overview

Earlier clinical trials suggest the vaccine causes an immune response in participants. But The trial includes 1000 participants here in Remdesivir is an anti-viral drug being tested at Strong Hospital on 16 patients. Local vaccination efforts continue as the University of Featuring: Stephen Dewhurst , PhD Vice Dean for research at the School of Medicine and Dentistry Angela Branche, MD Assistant ... Universal masking procedures will take effect Tuesday evening at University of

Photo Gallery

URMC enters another phase 3 clinical trial for potential COVID-19 vaccine
URMC enters another phase three vaccine trial
URMC entering second arm of federal study for potential COVID-19 treatment
URMC officials address staff furloughs (full briefing) - May 11, 2020
URMC opens clinic to continue vaccinating Phase 1b patients
URMC, Rochester Regional health expanding visitation beginning Monday
URMC: Strong is prepared in case of local outbreak
URMC officials: ‘Painfully apparent’ temporary workforce reduction is necessary
Forum on COVID-19 research and treatment
Rochester Responds: Coronavirus Research at URMC
URMC researchers discuss NIH study results for new COVID-19 treatment
URMC rescheduling some procedures during the pandemic
Sponsored
Sponsored
View Detailed Profile
URMC enters another phase 3 clinical trial for potential COVID-19 vaccine

URMC enters another phase 3 clinical trial for potential COVID-19 vaccine

Earlier clinical trials suggest the vaccine causes an immune response in participants. But

URMC enters another phase three vaccine trial

URMC enters another phase three vaccine trial

The trial includes 1000 participants here in

Sponsored
URMC entering second arm of federal study for potential COVID-19 treatment

URMC entering second arm of federal study for potential COVID-19 treatment

Remdesivir is an anti-viral drug being tested at Strong Hospital on 16 patients.

URMC officials address staff furloughs (full briefing) - May 11, 2020

URMC officials address staff furloughs (full briefing) - May 11, 2020

University of

URMC opens clinic to continue vaccinating Phase 1b patients

URMC opens clinic to continue vaccinating Phase 1b patients

Local vaccination efforts continue as the University of

Sponsored
URMC, Rochester Regional health expanding visitation beginning Monday

URMC, Rochester Regional health expanding visitation beginning Monday

Both

URMC: Strong is prepared in case of local outbreak

URMC: Strong is prepared in case of local outbreak

The University of

URMC officials: ‘Painfully apparent’ temporary workforce reduction is necessary

URMC officials: ‘Painfully apparent’ temporary workforce reduction is necessary

University of

Forum on COVID-19 research and treatment

Forum on COVID-19 research and treatment

Researchers from the University of

Rochester Responds: Coronavirus Research at URMC

Rochester Responds: Coronavirus Research at URMC

Featuring: Stephen Dewhurst , PhD Vice Dean for research at the School of Medicine and Dentistry Angela Branche, MD Assistant ...

URMC researchers discuss NIH study results for new COVID-19 treatment

URMC researchers discuss NIH study results for new COVID-19 treatment

Researchers with the

URMC rescheduling some procedures during the pandemic

URMC rescheduling some procedures during the pandemic

The University of

Universal masking takes effect at Rochester Regional & UR Medicine

Universal masking takes effect at Rochester Regional & UR Medicine

Universal masking procedures will take effect Tuesday evening at University of